TNF and inflammatory bowel disease: Among them, 29 (highlighted in Table S7) were considered eligible, i.e., they are modifiers of downstream molecular processes or molecules (more details in “Methods”), for the mechanistic interpretation of their alterations and possible consequences linked to the induction of remission in IBD patients after anti-TNF therapy exposure.